Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Azizi

Showing results (121-130 of 267) with videos related to

Pageof 27
Sort By:
Journal of the American Society of Nephrology : JASN|February 15, 2008
Reciprocal regulation of plasma apelin and vasopressin by osmotic stimuliMichel Azizi, Xavier Iturrioz, Anne Blanchard, et al.
Hypertension (Dallas, Tex. : 1979)|June 15, 2016
Evaluation of Adherence Should Become an Integral Part of Assessment of Patients With Apparently Treatment-Resistant HypertensionElena Berra, Michel Azizi, Arnaud Capron, et al.
European Journal of Preventive Cardiology|April 26, 2026
Predicting primary aldosteronism: risk stratification-based and machine learning-based modelsJean-Baptiste de Freminville, Laurence Amar, Jean Feydy, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 2, 2019
Adrenal adaptation in potassium-depleted men: role of progesterone?Anne Blanchard, Sylvie Brailly Tabard, Antonin Lamaziere, et al.
European Urology|January 23, 2009
Salvage therapy with bevacizumab-sunitinib combination after failure of sunitinib alone for metastatic renal cell carcinoma: a case seriesJacques Medioni, Eugeniu Banu, Dominique Helley, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|August 30, 2012
Dual RAAS suppression: recent developments and implications in light of the ALTITUDE studyRudolf A de Boer, Michel Azizi, Ah Jan Danser, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 5, 2018
Will SPYRAL HTN-OFF MED change my practice? SPYRAL HTN-OFF MED: a prospective, randomised, sham-controlled trial on renal denervation in the absence of antihypertensive medicationsLucas Lauder, Sebastian Ewen, Michel Azizi, et al.
Journal of Hypertension|November 3, 2016
Copeptin is increased in resistant hypertensionMargarida Mendes, Julie Dubourg, Anne Blanchard, et al.
Blood Pressure|February 8, 2018
Macrolides for KCNJ5-mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronismGiuseppe Maiolino, Giulio Ceolotto, Michele Battistel, et al.
Blood Pressure|August 16, 2021
Hypertension healthcare professional beliefs and behaviour regarding patient medication adherence: a survey conducted among European Society of Hypertension Centres of ExcellenceMichel Burnier, Aleksander Prejbisz, Thomas Weber, et al.
Pageof 27

Showing results (121-130 of 267) with videos related to

Sort By:
Pageof 27
Journal of the American Society of Nephrology : JASN|February 15, 2008
Reciprocal regulation of plasma apelin and vasopressin by osmotic stimuliMichel Azizi, Xavier Iturrioz, Anne Blanchard, et al.
Hypertension (Dallas, Tex. : 1979)|June 15, 2016
Evaluation of Adherence Should Become an Integral Part of Assessment of Patients With Apparently Treatment-Resistant HypertensionElena Berra, Michel Azizi, Arnaud Capron, et al.
European Journal of Preventive Cardiology|April 26, 2026
Predicting primary aldosteronism: risk stratification-based and machine learning-based modelsJean-Baptiste de Freminville, Laurence Amar, Jean Feydy, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 2, 2019
Adrenal adaptation in potassium-depleted men: role of progesterone?Anne Blanchard, Sylvie Brailly Tabard, Antonin Lamaziere, et al.
European Urology|January 23, 2009
Salvage therapy with bevacizumab-sunitinib combination after failure of sunitinib alone for metastatic renal cell carcinoma: a case seriesJacques Medioni, Eugeniu Banu, Dominique Helley, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|August 30, 2012
Dual RAAS suppression: recent developments and implications in light of the ALTITUDE studyRudolf A de Boer, Michel Azizi, Ah Jan Danser, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 5, 2018
Will SPYRAL HTN-OFF MED change my practice? SPYRAL HTN-OFF MED: a prospective, randomised, sham-controlled trial on renal denervation in the absence of antihypertensive medicationsLucas Lauder, Sebastian Ewen, Michel Azizi, et al.
Journal of Hypertension|November 3, 2016
Copeptin is increased in resistant hypertensionMargarida Mendes, Julie Dubourg, Anne Blanchard, et al.
Blood Pressure|February 8, 2018
Macrolides for KCNJ5-mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronismGiuseppe Maiolino, Giulio Ceolotto, Michele Battistel, et al.
Blood Pressure|August 16, 2021
Hypertension healthcare professional beliefs and behaviour regarding patient medication adherence: a survey conducted among European Society of Hypertension Centres of ExcellenceMichel Burnier, Aleksander Prejbisz, Thomas Weber, et al.
Pageof 27